HCB News: How did system developers leverage its experience from the previous company, Supersonic Imagine, in developing this dematerialized ultrasound system? CCB: The company has leveraged the expertise and experience gained from my previous company, Supersonic Imagine, where I was a co-founder, and which was acquired by Hologic. Supersonic Imagine was a pioneer in the development of advanced software for ultrasound image reconstruction and quantification. The knowledge and experience gained in this domain laid the foundation for transitioning from traditional hardware-based systems to a software-based approach. It was at Supersonic Imagine that we recognized the potential of dematerializing ultrasound and shifting the intelligence from hardware to software, but we did not have the technology to implement it. This experience served as a crucial steppingstone in the development of their current dematerialized ultrasound system, but the company developed specific IP to enable a complete “softwarization” of Ultrasound.
HCB News: How does the company's platform allows the development of clinical applications, and what are these potential applications? CCB: The company's Software platform is designed to be modular and agile, allowing E-Scopics for the development of applications, alone or through collaboration with third-party Medtech players. This platform architecture makes it possible to create specialized applications that can leverage the software-based ultrasound system's capabilities. Third-party developers can build applications targeting a wide range of clinical areas. The applications can spread along the patient care management from screening to therapy and can be categorized into two main groups:
One: Upstream Applications: These applications leverage the system's ability to quantify tissue properties and generate quantitative measurements. This quantification is foreseen as an enabler for healthcare professionals to adopt Ultrasound technology without having to interpret images. Measurements are used to assess and monitor patients’ health status. Potential applications include monitoring liver stiffness for hepatologists, assessing patients at risk of liver diseases, monitoring vascular diseases, evaluating rheumatoid arthritis, assessing gynecological conditions for fertility treatments, and many more.
Two: Downstream Applications: These applications are focused on interventional procedures while providing imaging guidance. They use the system to guide minimally invasive treatments. Examples include liver endoscopic surgery, vascular interventions, and many more.
